Search - tctmd.com

Displaying 481 - 500 of 739

Sort: Relevancy | Date

News Daily News

Un Abordaje ‘en Escopeta’ Parece Reducir las Rehospitalizaciones Post-PCI

Todd Neale

August 25, 2016

News Features

The Bioresorbable Stent Story So Far: What Promise? What Price?

Michael O'Riordan

August 17, 2016

News Daily News

One Map to Guide Them All: The Physician Who Hopes to Connect the Cardiology Dots

Michael H. Wilson

August 15, 2016

News Daily News

Coronary Perforations During PCI: Rare but Risky, BCIS Data Show

Caitlin E. Cox

August 05, 2016

News Daily News

Genetically Dictated Higher Lipid Levels Seem to Protect Against Type 2 Diabetes

Todd Neale

August 04, 2016

News Daily News

Apollo Lunar Astronauts Dying of Heart Disease Pose CV Safety Questions for Deep Space

Michael O'Riordan

August 01, 2016

News Daily News

PLATFORM: FFRCT-Guided Strategy in Suspected CAD ‘Durable’ Out to 1 Year

Michael O'Riordan

July 27, 2016

News Daily News

Medical Devices Approved More Quickly in EU Face More Safety Alerts and Recalls

Shelley Wood

July 05, 2016

News Daily News

TCTMD’s Top 10 Most Popular Stories for June 2016

Shelley Wood

July 01, 2016

News Daily News

Deadly Deceleration? Annual Declines in US Cardiovascular Death Rate Start to Slow

Caitlin E. Cox

June 30, 2016

News Conference News TVT 2016

To Intervene or Not to Intervene When the TAVR Patient Has CAD: New Insights

Shelley Wood

June 17, 2016

News Daily News

Survey of Interventional Cardiologists With Absorb BVS Expertise Gives Snapshot of Attitudes, Usage

Michael O'Riordan

June 14, 2016

News Daily News

Stimulant Drug Methylphenidate, Used for ADHD, Linked With Increased Risks of Arrhythmia, MI

Michael O'Riordan

June 01, 2016

News Conference News EuroPCR 2016

Studies Highlight Permanent Pacemaker Rates Among New-Generation TAVR Devices

Michael O'Riordan

May 23, 2016

News Conference News EuroPCR 2016

‘Obesity Paradox’ Alive, Well, and Mysterious After TAVR

Yael L. Maxwell

May 18, 2016

News Daily News

Healthy Hearts Linked to Lower Risk of Frailty in Old Age

Leah Lawrence

May 11, 2016

News Daily News

Real-World Study Largely Confirms Effects of Apixaban, Rivaroxaban for A-fib

Todd Neale

April 21, 2016

News Conference News ACC 2016

‘Enhanced’ Multicellular Stem Cell Therapy Improves Clinical Outcomes in Heart Failure: ixCELL-DCM Study

Michael O'Riordan

April 04, 2016

News Conference News ACC 2016

Statin Intolerance and FH: GAUSS-3 Finds Benefit With Evolocumab, While Another Study Exposes Lifetime Risks of FH

Michael O'Riordan

April 03, 2016

News Conference News ACC 2016

HOPE-3: Reducing LDL Cholesterol Improves Outcomes in Intermediate-Risk Patients, but BP-Lowering Does Not

Michael O'Riordan

April 02, 2016

Advertisement

Un Abordaje ‘en Escopeta’ Parece Reducir las Rehospitalizaciones Post-PCI

The Bioresorbable Stent Story So Far: What Promise? What Price?

One Map to Guide Them All: The Physician Who Hopes to Connect the Cardiology Dots

Coronary Perforations During PCI: Rare but Risky, BCIS Data Show

Genetically Dictated Higher Lipid Levels Seem to Protect Against Type 2 Diabetes

Apollo Lunar Astronauts Dying of Heart Disease Pose CV Safety Questions for Deep Space

PLATFORM: FFRCT-Guided Strategy in Suspected CAD ‘Durable’ Out to 1 Year

Medical Devices Approved More Quickly in EU Face More Safety Alerts and Recalls

TCTMD’s Top 10 Most Popular Stories for June 2016

Deadly Deceleration? Annual Declines in US Cardiovascular Death Rate Start to Slow

To Intervene or Not to Intervene When the TAVR Patient Has CAD: New Insights

Survey of Interventional Cardiologists With Absorb BVS Expertise Gives Snapshot of Attitudes, Usage

Stimulant Drug Methylphenidate, Used for ADHD, Linked With Increased Risks of Arrhythmia, MI

Studies Highlight Permanent Pacemaker Rates Among New-Generation TAVR Devices

‘Obesity Paradox’ Alive, Well, and Mysterious After TAVR

Healthy Hearts Linked to Lower Risk of Frailty in Old Age

Real-World Study Largely Confirms Effects of Apixaban, Rivaroxaban for A-fib

‘Enhanced’ Multicellular Stem Cell Therapy Improves Clinical Outcomes in Heart Failure: ixCELL-DCM Study

Statin Intolerance and FH: GAUSS-3 Finds Benefit With Evolocumab, While Another Study Exposes Lifetime Risks of FH

HOPE-3: Reducing LDL Cholesterol Improves Outcomes in Intermediate-Risk Patients, but BP-Lowering Does Not

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content